Tag Archives: MGEN

Analysts Offer Insights on Healthcare Companies: Miragen Therapeutics Inc (NASDAQ: MGEN), Athersys (NASDAQ: ATHX) and MannKind (NASDAQ: MNKD)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Miragen Therapeutics Inc (NASDAQ: MGEN), Athersys (NASDAQ: ATHX) and MannKind (NASDAQ: MNKD) with bullish sentiments. Miragen Therapeutics Inc (NASDAQ: MGEN) In a

Analysts Offer Insights on Healthcare Companies: Miragen Therapeutics Inc (NASDAQ: MGEN), Mesoblast Ltd (NASDAQ: MESO) and Ampliphi Biosciences (AMEX: APHB)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Miragen Therapeutics Inc (NASDAQ: MGEN), Mesoblast Ltd (NASDAQ: MESO) and Ampliphi Biosciences (AMEX: APHB) with bullish sentiments. Miragen Therapeutics Inc (NASDAQ: MGEN)

Miragen Therapeutics Inc Gets a Buy Rating from Oppenheimer

In a report released today, Leah R. Cann from Oppenheimer assigned a Buy rating to Miragen Therapeutics Inc (NASDAQ: MGEN), with a price target of $13. The company’s shares opened today at $6.82, close to its 52-week low of $5.01.

Cowen & Co. Maintains a Hold Rating on Miragen Therapeutics Inc

Cowen & Co. analyst Ritu Baral maintained a Hold rating on Miragen Therapeutics Inc (NASDAQ: MGEN) on April 6. The company’s shares closed on Friday at $6.50, close to its 52-week low of $5.01. According to TipRanks.com, Baral is a

miRagen Therapeutics Inc Receives a Buy from Oppenheimer

In a report released today, Leah R. Cann from Oppenheimer assigned a Buy rating to miRagen Therapeutics Inc (NASDAQ: MGEN), with a price target of $13. The company’s shares opened today at $8.06. R. Cann observed: “MiRagen Therapeutics announced today

Analysts Offer Insights on Healthcare Companies: miRagen Therapeutics Inc (NASDAQ: MGEN) and Edwards Lifesciences (NYSE: EW)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on miRagen Therapeutics Inc (NASDAQ: MGEN) and Edwards Lifesciences (NYSE: EW) with bullish sentiments. miRagen Therapeutics Inc (NASDAQ: MGEN) B.Riley FBR analyst Madhu